1. L Dirmantaite
Information acquired: 2025
L Dirmantaite is an academic who published a paper in 2023-12-01 entitled Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The paper was published in a journal entitled The Lancet. Diabetes & Endocrinology.